DECEMBER 15, 2004
VOLUME 1 NO. 23
 

Antidepressant scripts for kids take off like
a rocket — around the world

Should more children who can't cope with life's emotional
roller-coaster be medicated? Most docs say, "Yes"


When Mary Poppins taught her young wards that, "a spoonful of sugar makes the medicine go down," she probably wasn't referring to sertraline, paroxetine or any other antidepressant for that matter. But that was then. Nowadays, the growing trend to prescribe antidepressants to kids could spell the end of the carefree days of childhood as we know it. A 2000-2002 survey of physicians' prescribing habits in nine countries pointed to the rapidly increasing use of antidepressants in children. Canada is one of the few countries bucking this global trend — but don't celebrate yet. This may only be because its prescription rates of antidepressants to kids are already among the highest in the world, surpassed only by the US.

The research, published in the December issue of the Archives of Disease in Childhood, is based on records kept by 13,223 physicians in Canada, the UK, France, Germany, Spain, the US, Argentina, Brazil and Mexico. The study was based on an international database called IMS MIDAS Prescribing Insights, to which a representative sample of physicians from each country reported their prescribing habits for a few days each year.

HIGHS AND LOWS
The use of antidepressants and other psychotropic meds such as stimulants and calmants rose in all nine countries over the two-year period. The fastest increase was seen in Britain, where antidepressant use climbed 68%. The smallest increase was seen in Germany, where use rose by a statistically non-significant 13%. After Germany, Canada saw the most modest rise, at just under 15%.

In fact, Canadian prescriptions in this sample rose dramatically last year but this was counterbalanced by a fall in 2000-2001 — the only annual decline seen in any of the nine countries.

Another study in the same journal tracked the prescription of various antidepressant types in Britain between 1992 and 2001. Unsurprisingly, the figures showed a steady decline in the use of tricyclics (TCAs) and the irresistible rise of the selective serotonin reuptake inhibitors (SSRIs). However, TCAs were more likely to be used in the youngest children, though most prescriptions in the under-10 age group were for bedwetting. SSRIs, on the other hand, were mostly given to children with diagnosed depression.

Boys were more likely to take antidepressants young. Use soared in both sexes from age 15 on, and girls led the way there. The largest single increase was in SSRI use in girls aged 11 to 14, who were receiving 23 times as many prescriptions in 2001 as in 1992.

GROWING PAINS
Perhaps the most interesting finding was the poor compliance, suggestive of limited benefit, in this age group. A quarter of these patients switched drugs and most of these switched from one class to another. Among those diagnosed with depression, more than half discontinued treatment within two months. Those taking TCAs were particularly likely to stop treatment.

With the recently discovered link between SSRIs and child suicide, these figures may be frightening to some. However, Dr John Strauss, a mood disorder specialist at the University of Toronto's Centre for Addiction and Mental Health, cautioned against overreacting to the new SSRI warnings. "The black box warning is not a contraindication. Naturally, physicians will be concerned by reports of suicidality, but the overall risk is fairly small. To me, the most interesting aspect of the recent review of research, and the new data that has come out, is that these drugs are less effective in under-18s than previously thought."

Tricyclics are definitely not the answer, according to Dr Strauss. "It's pretty clear from the existing research that TCAs are not very useful in young patients." Physicians should remember that non-pharmaceutical approaches like cognitive behavioural therapy can be either an adjunct or an alternative to SSRIs, he added.

Physicians who do prescribe SSRIs to young patients should monitor them closely at the outset for signs of suicidality, hostility or manic behaviour, advised Dr Strauss. "It's generally accepted today that these drugs can bring to the surface previously undiagnosed symptoms of bipolar disorders."

 

 

back to top of page

 

 

 

 
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T.